Three Vanderbilt-Ingram Cancer Center (VICC) investigators have been awarded breast cancer research grants totaling $830,000 from the Susan G. Komen organization.
News: Breast CancerNext Page »« Previous Page
A new Vanderbilt University School of Nursing (VUSN) study may lead to earlier detection and better outcomes for the 20-30 percent of breast cancer patients with lymphedema, the painful and stigmatizing arm swelling that often results from treatment.
Targeting a cytokine pathway may offer a way to inhibit breast cancer cell survival and metastasis, study suggests.
by Leigh MacMillan The protein MTBP is important for growth and survival of triple negative breast cancer (TNBC) – a clinically aggressive subtype of breast cancer that is commonly resistant to targeted therapeutics – Vanderbilt investigators have discovered. Using data from The Cancer Genome Atlas, Christine Eischen, Ph.D., MSTP student Brian Grieb, Ph.D., and colleagues […]
by Dagny Stuart Two Vanderbilt-Ingram Cancer Center investigators have received multi-year breast cancer research grants from the Susan G. Komen for the Cure Breast Cancer Foundation. Justin Balko, Ph.D., Pharm.D., research assistant professor of Medicine, won support for his research project which will use molecular profiling to prioritize adjuvant targeted therapy for triple negative breast […]
by Dagny Stuart A new study in East Asian women has identified three genetic changes linked to an increased risk of breast cancer. The research, led by Vanderbilt University investigators, was published online this week in Nature Genetics. While breast cancer is one of the most common malignancies among women worldwide, most studies of the […]
by Dagny Stuart Vandana Abramson, M.D., assistant professor of Medicine and a breast cancer specialist at Vanderbilt-Ingram Cancer Center, has received the Advanced Clinical Research Award in Breast Cancer from the Conquer Cancer Foundation (CCF). The CCF grants and awards support cancer research done by physician-scientists at every stage of their careers. Abramson’s […]
by Bill Snyder A protein essential for growth of normal breast tissue also may play a role in breast cancer, Vanderbilt University researchers have found. Reporting recently in Nature Cell Biology, Yongliang Huo, Ph.D., and Ian Macara, Ph.D., for the first time describe the function of a protein called Par3L, which is expressed by a […]
by Dagny Stuart Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center, has been named an at-large member of the National Cancer Policy Forum, an advisory group of the Institute of Medicine (IOM) of the National Academies. The IOM established the forum to serve as a trusted venue for […]
Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology and Donna S. Hall Professor of Breast Cancer Research at Vanderbilt-Ingram Cancer Center, has assumed the presidency of the American Association for Cancer Research (AACR) for 2014-2015. He was inaugurated during the AACR Annual Meeting which was held April 5-9, in San Diego. AACR, founded […]